Knowledge of Anal Cancer, Anal Cancer Screening, and HPV in HIV-Positive and High-Risk HIV-Negative Women
- PMID: 30850945
- PMCID: PMC6732243
- DOI: 10.1007/s13187-019-01503-8
Knowledge of Anal Cancer, Anal Cancer Screening, and HPV in HIV-Positive and High-Risk HIV-Negative Women
Abstract
The incidence of anal cancer in HIV-positive women is a growing public health concern where they have a 7.8-fold increased risk for anal cancer than women in the general population. We examined knowledge of anal cancer, anal cancer screening, and HPV in HIV-positive women and high-risk HIV-negative women. Women were recruited from the Women's Interagency HIV Study and completed an adapted Knowledge of Anal Cancer and HPV Scale. Correlations among anal cancer knowledge and sociodemographic and risk factors were assessed using Pearson's or Spearman's rho r test. Student's t test or chi-square tests identified significant differences between groups by HIV status or risk factors. Among 155 women, 72% (n = 113) correctly identified the purpose of an anal Pap test. However, only 42% (n = 65) identified HIV as a risk factor for anal cancer. HIV-positive women were more knowledgeable about anal cancer than high risk HIV-negative women (t = 2.104, p = .037). Women with a history of an abnormal cervical Pap test (t = 2.137, p = .034), younger age (t = 3.716, p = .000), reported history of anal sex (t = 3.284, p = .001), some college education or higher (t = -2.005, p = .047), and non-smokers (t = 2.425, p = .016) were significantly more knowledgeable about HPV. Although most women were knowledgeable about anal cancer, many women could not identify important risk factors for anal cancer, such as HIV infection. Patient educational interventions tailored to HIV-positive women are warranted to improve knowledge and awareness of risk for anal cancer.
Keywords: Anal Pap test; Anal cancer; Knowledge; Women.
Similar articles
-
Concomitant anal and cervical human papillomavirusV infections and intraepithelial neoplasia in HIV-infected and uninfected women.AIDS. 2013 Jul 17;27(11):1743-51. doi: 10.1097/QAD.0b013e3283601b09. AIDS. 2013. PMID: 23803793 Free PMC article.
-
Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer.Cancer Cytopathol. 2018 Jul;126(7):461-470. doi: 10.1002/cncy.22003. Epub 2018 Apr 25. Cancer Cytopathol. 2018. PMID: 29694716
-
HPV-Associated Anal Cancer in the HIV/AIDS Patient.Cancer Treat Res. 2019;177:183-209. doi: 10.1007/978-3-030-03502-0_7. Cancer Treat Res. 2019. PMID: 30523625 Review.
-
Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women.Cancer Cytopathol. 2019 Jun;127(6):407-413. doi: 10.1002/cncy.22151. Epub 2019 May 30. Cancer Cytopathol. 2019. PMID: 31145557
-
Human papillomavirus-associated diseases in HIV-infected men who have sex with men.Curr Opin Infect Dis. 2009 Apr;22(2):109-14. doi: 10.1097/QCO.0b013e3283229fc8. Curr Opin Infect Dis. 2009. PMID: 19276878 Review.
Cited by
-
A Brief Review of Anal Cancer Screening Methods for Prevention and Earlier Diagnosis.Cureus. 2025 Mar 16;17(3):e80686. doi: 10.7759/cureus.80686. eCollection 2025 Mar. Cureus. 2025. PMID: 40242694 Free PMC article. Review.
-
An overview of implementing an evidence based program to increase HPV vaccination in HIV community clinics.BMC Public Health. 2022 Sep 7;22(1):1696. doi: 10.1186/s12889-022-14100-0. BMC Public Health. 2022. PMID: 36071389 Free PMC article.
-
Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.Curr Oncol. 2020 Jun;27(3):e294-e306. doi: 10.3747/co.27.6061. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669936 Free PMC article.
-
Anal cancer screening among women with HIV: provider experiences and system-level challenges.AIDS Care. 2022 Feb;34(2):220-226. doi: 10.1080/09540121.2021.1883512. Epub 2021 Feb 17. AIDS Care. 2022. PMID: 33594934 Free PMC article.
-
Integrating HPV Vaccination Within PrEP care Delivery for Underserved Populations: A Mixed Methods Feasibility Study.J Community Health. 2023 Aug;48(4):640-651. doi: 10.1007/s10900-023-01202-y. Epub 2023 Mar 10. J Community Health. 2023. PMID: 36894796 Free PMC article.
References
-
- Frisch Morten, Biggar Robert J, and Goedert James J. 2000. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of the National Cancer Institute 92 (18):1500–1510. - PubMed
-
- Chin-Hong Peter V., and Palefsky Joel M.. 2005. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatologic Therapy 18 (1):67–76. - PubMed
-
- Palefsky Joel M. a, Holly Elizabeth A., Ralston Mary L., Da Costa Maria, and Greenblatt Ruth M.. 2001. Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV-Negative Women. Journal of Infectious Diseases 183 (3):383–391. - PubMed
-
- Kojic Erna Milunka, Cu-Uvin Susan, Conley Lois, Bush Tim, Onyekwuluje Juanita, Swan David C, Unger Elizabeth R, Henry Keith, Hammer John H, and Overton Edgar T. 2011. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sexually Transmitted Diseases 38 (4):253–259. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 HL146241/HL/NHLBI NIH HHS/United States
- U01 AI103397/AI/NIAID NIH HHS/United States
- U54 AG062334/AG/NIA NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- U01 AI103401/AI/NIAID NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 AI103408/AI/NIAID NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- R38 AI140299/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- R21 AG059505/AG/NIA NIH HHS/United States
- U01 AI103390/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials